跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 94 条关于
“CLN3”
全部
94
临床试验
59
药物
19
机构
0
资讯
16
22天前
New Retina Model Reveals How CLN3-Batten Disease Damages Vision and Points to a Treatment
3个月前
Batten-1 Advances Toward Pivotal Phase 3 Trial as THX Pharma, Biocodex, and BBDF Unite on International Batten Disease Awareness Day
7个月前
Azafaros to Present Phase 3 Nizubaglustat Data for Rare Lysosomal Storage Disorders at WORLDSymposium 2026
去年
NCL Translational Research Conference Highlights Advances in Batten Disease Therapies
去年
Personalized ASO Treatment Fast-Tracked for Twins with Rare Batten Disease
去年
Miglustat Shows Promise in Stabilizing Vision in Juvenile Batten Disease
7个月前
THX Pharma and Biocodex Forge €173 Million Licensing Deal for Rare Neurological Disease Treatments
2年前
FDA Expands Brineura Approval to Include All Ages with CLN2 Disease
去年
Novel Nanoparticle Therapy Agg-CLNP Shows Promise for Preventing Rheumatoid Arthritis and Reducing Flares
去年
NICE Extends Access to Brineura for CLN2 Batten Disease While Seeking Long-term Solution
第 1 页,共 2 页
上一页
下一页